CN115650929A - Isoxazoline-containing ester compound, preparation method and application - Google Patents

Isoxazoline-containing ester compound, preparation method and application Download PDF

Info

Publication number
CN115650929A
CN115650929A CN202211404419.4A CN202211404419A CN115650929A CN 115650929 A CN115650929 A CN 115650929A CN 202211404419 A CN202211404419 A CN 202211404419A CN 115650929 A CN115650929 A CN 115650929A
Authority
CN
China
Prior art keywords
isoxazoline
halogenated
formula
alkyl
haloc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202211404419.4A
Other languages
Chinese (zh)
Other versions
CN115650929B (en
Inventor
雷鹏
张彩霞
马志卿
高艳清
李文奎
陈光友
闫合
冯俊涛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northwest A&F University
Original Assignee
Northwest A&F University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northwest A&F University filed Critical Northwest A&F University
Priority to CN202211404419.4A priority Critical patent/CN115650929B/en
Publication of CN115650929A publication Critical patent/CN115650929A/en
Application granted granted Critical
Publication of CN115650929B publication Critical patent/CN115650929B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

The invention discloses an ester compound containing isoxazoline, a preparation method and application. The invention introduces active groups such as ester, sulfonate, carbamate and the like with excellent biological activity into an isoxazoline structure to obtain a compound with a novel structure. The structure of the compound is shown as formula I:

Description

Ester compound containing isoxazoline, preparation method and application
Technical Field
The invention belongs to the technical field of agricultural pest control, and particularly relates to an isoxazoline-containing ester compound, and a preparation method and application thereof.
Background
The traditional chemical pesticide is limited or prohibited due to the problems of high residue, high resistance, high toxicity and the like. How to develop products with high activity, high selectivity, low risk and low residue has become the development direction of green pesticides. New non-competitive antagonists of GABA receptors, isoxazolines, such as Fluralaner, afoxalaner, sarolaner, fluxamide, etc., that may act on the TM1 and TM3 regions of GABA receptors have been reported in recent years (Vet Parasitol,2014,201,179, institute Biochem Mol biol, 2014,45, 111.
The isoxazoline pesticide acts on a GABA receptor chloride ion channel and shows obvious biological activity on agricultural pests and sanitary pests. Fluralaner is used as a classical isoxazoline insecticide, and the development system, the development process and the development mode thereof provide conditions for the successful design and development of the isoxazoline insecticides such as Afoxalaner, sarolaner and Fluxamide. Wherein, 5-trifluoromethyl-3-phenyl-5-substituted phenyl isoxazoline is an isoxazoline insecticide core active structure and is worthy of further research on the derivation thereof. Lahm et al, duPont, USA, reports the insecticidal activity of a series of isoxazoline-containing ester compounds that are structurally similar to Fluralaner (Bioorg Med Chem Lett,2013,23, 3001).
It is well known that carbamates, esters and sulfonates capable of hydrogen bonding are active groups commonly used in pesticides due to their respective advantages. Carbamate insecticides (e.g., meta-tolyl-methylcarbamate) inhibit acetylcholinesterase (AChE) in the insect nervous system by covalently carbamylating serine residues within the insecticidal active site. Many ester insecticides, such as pyrethroid insecticides, bind to voltage-gated sodium channels and alter their gating kinetics, thereby disrupting neural function (pesticide Sci,2008,33, 371). Most of sulfone compounds have excellent biological activity, particularly in the field of pesticides, such as excellent insecticidal activity and antifungal activity, in order to find a novel agricultural pesticide, the inventor introduces active group fragments commonly used in carbamate, ester and sulfonate pesticides capable of forming hydrogen bonds into an isoxazoline core structure to obtain compounds with novel structures shown in formula I, and finds that the compounds have good effect of preventing and controlling plant pests. At present, no report that carbamate, ester and sulfonate are introduced into an isoxazoline core structure exists, and therefore, the invention discloses an isoxazoline-containing ester compound with a novel structure and application of the isoxazoline-containing ester compound as an agricultural pesticide.
Disclosure of Invention
The invention aims to provide an ester compound containing isoxazoline, a preparation method and application.
An ester compound containing isoxazoline is a compound shown as a formula I;
Figure BDA0003936242660000021
in the formula: a. The 1 One of substituted or unsubstituted benzene ring, nitrogen-containing heterocycle and oxygen-containing heterocycle is selected, the substitution mode is mono-substituted or polysubstituted, and the substituent is as follows: one of hydrogen, C1-C12 alkyl, halogenated C1-C12 alkyl, C1-C12 alkoxy, halogenated C1-C12 alkoxy, C3-C12 cycloalkyl, C1-C12 alkylthio, C2-C12 alkenyl, C2-C12 alkenylthio, halogenated C2-C12 alkenyl, C2-C12 alkynyl, halogenated C2-C12 alkynyl, halogen, cyano, nitro and benzyloxy.
R 1 One selected from the group consisting of hydrogen, C1-C12 alkyl, halogenated C1-C12 alkyl, C1-C12 alkoxy, halogenated C1-C12 alkoxy, C3-C12 cycloalkyl, C1-C12 alkylthio, C2-C12 alkenyl, C2-C12 alkenylthio, halogenated C2-C12 alkenyl, C2-C12 alkynyl, halogenated C2-C12 alkynyl, halogen, cyano, nitro and benzyloxy;
A 2 is one of substituted or unsubstituted benzene ring, nitrogen-containing heterocycle, oxygen-containing heterocycle and sulfur-containing heterocycle, the substitution mode is single substitution or polysubstitution, and the stituent is selected from hydrogen, C1-C12 alkyl, halogenated C1-C12 alkyl, C1-C12 alkoxy, halogenated C1-C12 alkoxy, C3-C12 cycloalkyl, C1-C12 alkylthio, C2-C12 alkenyl, C2-C12 alkenylthioOne of a group, a halogenated C2-C12 alkenyl group, a C2-C12 alkynyl group, a halogenated C2-C12 alkynyl group, a halogen group, a cyano group, a nitro group and a benzyloxy group;
x is C or S;
n is 1 or 2;
R 2 one selected from the group consisting of C1-C12 alkyl, haloC 1-C12 alkyl, C1-C12 alkoxy, haloC 1-C12 alkoxy, C3-C12 cycloalkyl, haloC 3-C12 cycloalkyl, C1-C12 alkylthio, C2-C12 alkenyl, C2-C12 alkenylthio, haloC 2-C12 alkenyl, C2-C12 alkynyl, haloC 2-C12 alkynyl, C1-C12 alkylamino, haloC 1-C12 alkylamino, C1-C12 alkylaminocarbonyl, C1-C12 alkylsulfonyl, C1-C12 alkylsulfinyl, haloC 1-C12 alkylsulfonyl, C1-C12 alkylaminosulfonyl, di (C1-C12 alkyl) aminosulfonyl, acetyl, and formyl;
or, R 2 One of unsubstituted or substituted benzene ring, nitrogen-containing heterocycle, oxygen-containing heterocycle and sulfur-containing heterocycle is selected, the substitution mode is mono-substituted or polysubstituted, and the substituent is as follows: one of hydrogen, C1-C12 alkyl, halogenated C1-C12 alkyl, C1-C12 alkoxy, halogenated C1-C12 alkoxy, C3-C12 cycloalkyl, C1-C12 alkylthio, C2-C12 alkenyl, C2-C12 alkenylthio, halogenated C2-C12 alkenyl, C2-C12 alkynyl, halogenated C2-C12 alkynyl, acetyl, formyl, halogen, cyano, nitro and benzyloxy.
An ester compound containing isoxazoline is a compound shown as a formula I;
Figure BDA0003936242660000031
specific substituents in formula i are shown in the following table:
Figure BDA0003936242660000032
Figure BDA0003936242660000041
the preparation method of the ester compound containing the isoxazoline is characterized in that the ester compound containing the isoxazoline is the ester compound containing the isoxazoline;
the method comprises the following steps: reacting a compound shown in a formula II with a compound shown in a formula III or a compound shown in a formula IV in an organic solvent to obtain a compound shown in a formula I:
Figure BDA0003936242660000051
optionally, an additive is mixed into the organic solvent, the additive is selected from one or more of triethylamine, pyridine, dicyclohexylcarbodiimide, 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide, 4-dimethylaminopyridine and bis (4-nitrophenyl) carbonate, and the organic solvent is selected from one of dichloromethane, toluene, ethyl acetate and tetrahydrofuran.
Optionally, the reaction temperature of the reaction is 0-55 ℃, and the reaction time is 5 min-24 h.
Optionally, the molar ratio of the compound shown in the formula III to the compound shown in the formula II is 1 (0.5-1.5); the molar ratio of the compound shown in the formula IV to the compound shown in the formula II is 1 (0.5-1.5).
The use of an isoxazoline-containing ester compound according to any one of the present invention or an isoxazoline-containing ester compound produced by the method for producing an isoxazoline-containing ester compound according to any one of the present invention for producing an insecticide.
Optionally, the pesticide is used for preventing and treating wigglers, armyworms, pea aphids or diamond back moths.
An insecticide containing an isoxazoline-containing ester compound according to any one of the present invention or an isoxazoline-containing ester compound produced by the method for producing an isoxazoline-containing ester compound according to any one of the present invention.
Optionally, the pesticide is used for controlling diamondback moth, armyworm, pea aphid or wiggler.
The invention has the beneficial effects that:
the isoxazoline-containing ester compound disclosed by the invention has a novel structure, has broad-spectrum insecticidal activity, and particularly has an obvious insecticidal effect on pea aphids, armyworms, diamond back moths and wigglers.
Drawings
The accompanying drawings, which are included to provide a further understanding of the disclosure and are incorporated in and constitute a part of this specification, illustrate embodiments of the disclosure and together with the description serve to explain the disclosure without limiting the disclosure. In the drawings:
FIG. 1 is a hydrogen spectrum of compound I-01 of the present invention;
FIG. 2 is a carbon spectrum of Compound I-01 of the present invention;
FIG. 3 is a hydrogen spectrum of compound I-18 of the present invention;
FIG. 4 is a hydrogen spectrum of compound I-31 of the present invention.
Detailed Description
The present invention will be further described with reference to the following specific examples, but the present invention is not limited to these examples. The methods are conventional methods unless otherwise specified. The materials are commercially available from the open literature unless otherwise specified.
The invention discloses an ester compound containing isoxazoline, which is a compound shown in a formula I;
Figure BDA0003936242660000061
in the formula: a. The 1 One of substituted or unsubstituted benzene ring, nitrogen-containing heterocycle and oxygen-containing heterocycle is selected, the substitution mode is monosubstituted or polysubstituted, and the substituent is: one of hydrogen, C1-C12 alkyl, halogenated C1-C12 alkyl, C1-C12 alkoxy, halogenated C1-C12 alkoxy, C3-C12 cycloalkyl, C1-C12 alkylthio, C2-C12 alkenyl, C2-C12 alkenylthio, halogenated C2-C12 alkenyl, C2-C12 alkynyl, halogenated C2-C12 alkynyl, halogen, cyano, nitro and benzyloxy.
R 1 Selected from the group consisting of hydrogen, C1-C12 alkyl, haloC 1-C12 alkyl, C1-C12 alkoxy, haloC 1-C12 alkoxy, C3-C12 ringOne of alkyl, C1-C12 alkylthio, C2-C12 alkenyl, C2-C12 alkenylthio, halogenated C2-C12 alkenyl, C2-C12 alkynyl, halogenated C2-C12 alkynyl, halogen, cyano, nitro and benzyloxy;
A 2 the substituted heterocyclic ring is one of substituted or unsubstituted benzene ring, nitrogen-containing heterocyclic ring, oxygen-containing heterocyclic ring and sulfur-containing heterocyclic ring, the substitution mode is single substitution or multiple substitution, and the substituent is selected from one of hydrogen, C1-C12 alkyl, halogenated C1-C12 alkyl, C1-C12 alkoxy, halogenated C1-C12 alkoxy, C3-C12 cycloalkyl, C1-C12 alkylthio, C2-C12 alkenyl, C2-C12 alkenylthio, halogenated C2-C12 alkenyl, C2-C12 alkynyl, halogenated C2-C12 alkynyl, halogen, cyano, nitro and benzyloxy;
x is C or S;
n is 1 or 2;
R 2 one selected from the group consisting of C1-C12 alkyl, haloC 1-C12 alkyl, C1-C12 alkoxy, haloC 1-C12 alkoxy, C3-C12 cycloalkyl, haloC 3-C12 cycloalkyl, C1-C12 alkylthio, C2-C12 alkenyl, C2-C12 alkenylthio, haloC 2-C12 alkenyl, C2-C12 alkynyl, haloC 2-C12 alkynyl, C1-C12 alkylamino, haloC 1-C12 alkylamino, C1-C12 alkylaminocarbonyl, C1-C12 alkylsulfonyl, C1-C12 alkylsulfinyl, haloC 1-C12 alkylsulfonyl, C1-C12 alkylaminosulfonyl, di (C1-C12 alkyl) aminosulfonyl, acetyl, and formyl.
Or, R 2 One selected from unsubstituted or substituted benzene rings, nitrogen-containing heterocycles, oxygen-containing heterocycles, and sulfur-containing heterocycles. The substitution mode is mono-substituted or multi-substituted, and the substituent groups are as follows: one of hydrogen, C1-C12 alkyl, halogenated C1-C12 alkyl, C1-C12 alkoxy, halogenated C1-C12 alkoxy, C3-C12 cycloalkyl, C1-C12 alkylthio, C2-C12 alkenyl, C2-C12 alkenylthio, halogenated C2-C12 alkenyl, C2-C12 alkynyl, halogenated C2-C12 alkynyl, acetyl, formyl, halogen, cyano, nitro and benzyloxy.
In more detail, see table 1 for data:
TABLE 1
Figure BDA0003936242660000071
Figure BDA0003936242660000081
The reagent ratios used are volume ratios unless otherwise specified below.
Example 1: preparation of 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenyl-ethyl sulfonate (I-01):
Figure BDA0003936242660000082
in a 25mL single neck flask was added 1.88g (5 mmol) of 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenol, 0.66g (6.5 mmol) of triethylamine and 20mL of dichloromethane, 0.66g (6 mmol) of ethanesulfonic acid, 1.9g (10 mmol) of 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide and 6mg (0.25 mmol) of 4-dimethylaminopyridine, the reaction was stirred at room temperature for 24h, purified by column chromatography (petroleum ether: ethyl acetate = 8) and dried to give 1.25g of a white solid, yield 54%, melting point: 109.2-110.8 ℃ of the total weight, 1 HNMR(500MHz,Chloroform-d)δ7.71(d,J=8.8Hz,2H),7.50(s,2H),7.43(s,1H),7.35(d,J=8.8Hz,2H),4.07(d,J=17.1Hz,1H),3.69(d,J=17.2Hz,1H),3.32(q,J=7.4Hz,2H),1.55(t,J=7.4Hz,3H). 13 C NMR(126MHz,CDCl 3 ) δ 155.06,150.79,138.91,135.67,129.83,128.68,126.66,125.31,122.68,87.41 (q, J =30.4 Hz), 45.66,44.02,8.26. Specific hydrogen spectra and carbon spectra are detailed in figures 1 and 2.
Example 2: preparation of 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenyl-trifluoromethyl-ethyl sulfonate (I-02):
Figure BDA0003936242660000091
a25 ml single-neck flask was charged with 1.87g (5 mmol) of 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenol, and triethyleneAmine 0.66g (6.5 mmol) and 15mL dichloromethane, then under ice-bath conditions (0 ℃), to which is added dropwise a solution of trifluoromethyl-ethylsulfonyl chloride 1.18g (6 mmol) in 5mL dichloromethane, after which the reaction is stirred at room temperature for 24h, purified by column chromatography (petroleum ether: ethyl acetate = 8), dried to give 0.80g of a white solid, yield 30%, melting point: 99.0-99.8 ℃. 1 HNMR(500MHz,Chloroform-d)δ7.79(d,J=8.8Hz,2H),7.55(s,2H),7.48(s,1H),7.39(d,J=8.8Hz,2H),4.12(d,J=17.2Hz,1H),3.76(s,1H),3.57(d,J=8.3Hz,2H),2.92–2.78(m,2H).
The corresponding products I-03 to I-17 can be obtained by the same method as the preparation of the compounds I-01 to I-02, wherein the appearance, yield, melting point and melting point of the compounds are as follows, and only the substituted sulfonic acids are replaced to react with 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenol 1 The HNMR spectra data are shown below.
The compound 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenyl-propyl-1-sulfonate (I-03): white solid, yield 32%, melting point: the temperature of the mixture is between 89.9 and 92.3 ℃, 1 HNMR(500MHz,Chloroform-d)δ7.75(d,J=8.8Hz,2H),7.55(s,2H),7.47(t,J=1.9Hz,1H),7.38(s,2H),4.11(d,J=17.2Hz,1H),3.74(d,J=17.2Hz,1H),3.46–3.17(m,2H),2.16–1.96(m,2H),1.18(t,J=7.5Hz,3H).
the compound 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenyl-cyclopropyl sulfonate (I-04): white solid, yield 50%, melting point: the temperature of the mixture is between 123.1 and 124.8 ℃, 1 HNMR(500MHz,Chloroform-d)δ7.75(d,J=8.8Hz,2H),7.55(s,2H),7.47(s,1H),7.41(d,J=8.8Hz,2H),4.12(d,J=17.2Hz,1H),3.74(d,J=17.3Hz,1H),2.66(ddd,J=12.8,8.0,4.8Hz,1H),1.32(dt,J=7.1,3.6Hz,2H),1.19(dd,J=8.0,2.2Hz,2H).
the compound 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenyl-butyl-1-sulfonate (I-05): yellow solid, yield 45%, melting point: the temperature of the mixture is between 83.5 and 84.9 ℃, 1 HNMR(500MHz,Chloroform-d)δ7.62(d,J=8.8Hz,2H),7.41(s,2H),7.34(s,1H),7.24(d,J=8.8Hz,2H),3.98(d,J=17.2Hz,1H),3.60(d,J=17.2Hz,1H),3.26–3.04(m,2H),1.87(p,J=7.7Hz,2H),1.43(q,J=7.5Hz,2H),0.90(t,J=7.4Hz,3H).
the compound 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenyl-isobutyl-1-sulfonate (I-06): yellow solid, yield 57%, melting point: the temperature of the mixture is between 81.7 and 82.5 ℃, 1 HNMR(500MHz,Chloroform-d)δ7.75(d,J=6.7Hz,2H),7.55(s,2H),7.47(s,1H),7.38(d,J=8.7Hz,2H),4.11(d,J=17.2Hz,1H),3.73(d,J=17.2Hz,1H),3.23(d,J=6.6Hz,2H),2.48(dt,J=13.5,6.7Hz,1H),1.22(d,J=6.7Hz,6H).
the compound 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenyl-dimethylsulfamate (I-07): yellow solid, yield 48%, melting point: the temperature of the mixture is between 87.9 and 89.1 ℃, 1 HNMR(500MHz,Chloroform-d)δ7.74(d,J=8.8Hz,2H),7.56(s,2H),7.47(s,1H),7.39(d,J=8.8Hz,2H),4.12(d,J=17.2Hz,1H),3.74(d,J=17.2Hz,1H),3.04(s,6H).
the compound 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenyl-2-fluorobenzenesulfonate (I-08): yellow solid, yield 42%, melting point: 118.7-119.5 deg.c, 1 HNMR(500MHz,Chloroform-d)δ7.90(dd,J=8.9,4.9Hz,2H),7.67(d,J=6.8Hz,2H),7.54(s,2H),7.46(s,1H),7.26(t,J=8.5Hz,2H),7.12(d,J=8.8Hz,2H),4.10(d,J=17.2Hz,1H),3.72(d,J=17.2Hz,1H).
the compound 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenyl-3-fluorobenzenesulfonate (I-09): yellow solid, yield 40%, melting point: 112.5 to 113.8 ℃, 1 HNMR(500MHz,Chloroform-d)δ7.67–7.62(m,3H),7.60–7.54(m,2H),7.51(s,2H),7.46–7.39(m,2H),7.11(d,J=8.9Hz,2H),4.08(d,J=17.2Hz,1H),3.70(d,J=17.2Hz,1H).
the compound 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenyl-4-fluorobenzenesulfonate (I-10): yellow solid, yield 45%, melting point: the temperature of the mixture is between 82.6 and 83.7 ℃, 1 HNMR(500MHz,Chloroform-d)δ7.89(dd,J=8.9,4.9Hz,2H),7.66(d,J=8.8Hz,2H),7.53(s,2H),7.46(s,1H),7.26(t,J=8.5Hz,2H),7.11(d,J=8.8Hz,2H),4.10(d,J=17.2Hz,1H),3.71(d,J=17.2Hz,1H).
the compound 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl)Yl) -4, 5-dihydroisoxazol-3-yl) phenyl-2-chlorobenzenesulfonate (I-11): yellow solid, yield 38%, melting point: the temperature of the mixture is between 125.6 and 126.5 ℃, 1 HNMR(500MHz,Chloroform-d)δ7.96(dd,J=7.9,1.6Hz,1H),7.70–7.60(m,4H),7.52(s,2H),7.47–7.38(m,2H),7.24(d,J=8.8Hz,2H),4.09(d,J=17.2Hz,1H),3.71(d,J=17.3Hz,1H).
the compound 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenyl-3-chlorobenzenesulfonate (I-12): yellow solid, yield 38%, melting point: 113.0-114.1 deg.c, 1 HNMR(500MHz,Chloroform-d)δ7.88(s,1H),7.74(d,J=6.8Hz,1H),7.67(d,J=8.8Hz,3H),7.53(d,J=6.7Hz,3H),7.45(t,J=2.0Hz,1H),7.12(d,J=8.7Hz,2H),4.10(d,J=17.2Hz,1H),3.72(d,J=17.2Hz,1H).
the compound 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenyl-4-chlorobenzenesulfonate (I-13): white solid, yield 43%, melting point: 135.7-136.5 ℃ of water, 1 HNMR(500MHz,Chloroform-d)δ7.80(d,J=8.7Hz,2H),7.66(d,J=8.7Hz,2H),7.58–7.51(m,4H),7.46(d,J=1.8Hz,1H),7.11(d,J=8.7Hz,2H),4.10(d,J=17.2Hz,1H),3.72(d,J=17.2Hz,1H).
the compound 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenyl-4-cyanobenzenesulfonate (I-14): white solid, yield 53%, melting point: 122.6 to 124.1 ℃ of water, 1 HNMR(500MHz,Chloroform-d)δ7.95(d,J=8.6Hz,2H),7.84(d,J=6.7Hz,2H),7.63(d,J=8.8Hz,2H),7.47(s,2H),7.41(s,1H),7.06(d,J=8.8Hz,2H),4.05(d,J=17.2Hz,1H),3.67(d,J=17.3Hz,1H).
the compound 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenyl-4-methylbenzenesulfonate (I-15): yellow solid, yield 60%, melting point: the temperature of the mixture is between 113.6 and 115.1 ℃, 1 HNMR(500MHz,Chloroform-d)δ7.63(d,J=8.3Hz,2H),7.53(d,J=8.8Hz,2H),7.43(s,2H),7.36(s,1H),7.26(d,J=7.9Hz,2H),6.99(d,J=8.8Hz,2H),3.99(d,J=17.2Hz,1H),3.60(d,J=17.2Hz,1H),2.39(s,2H).
the compound 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenyl-4-methoxybenzenesulfonate (I-16): white solid, yield 56%, melting point: the temperature of the mixed solution is between 129.1 and 130.5 ℃, 1 HNMR(500MHz,Chloroform-d)δ7.64(d,J=8.9Hz,1H),7.50(d,J=8.8Hz,1H),7.40(s,1H),7.32(t,J=1.9Hz,1H),6.96(d,J=8.7Hz,1H),6.88(d,J=8.8Hz,1H),3.96(d,J=17.3Hz,1H),3.79(s,2H),3.58(d,J=17.2Hz,1H).
the compound 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenyl-thiophene-2-sulfonate (I-17): yellow solid, yield 42%, melting point: 124.1 to 125.5 ℃, 1 HNMR(500MHz,Chloroform-d)δ7.68(d,J=5.0Hz,1H),7.56(d,J=8.4Hz,2H),7.53(d,J=3.8Hz,1H),7.43(s,2H),7.36(s,1H),7.06(d,J=8.3Hz,3H),3.99(d,J=17.2Hz,1H),3.60(d,J=17.2Hz,1H).
example 3: preparation of 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenyl-2-methylbenzoate (I-18):
Figure BDA0003936242660000121
in a 25mL single neck flask were added 1.87g (5 mmol) of 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenol and 15mL of dichloromethane, added 0.82g (6 mmol) of 2-methylbenzoic acid, 0.66g (6.5 mmol) of triethylamine, 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide, 1.9g (10 mmol) and 6mg (0.25 mmol) of 4-dimethylaminopyridine, stirred at room temperature for 24h, column chromatographically purified (petroleum ether: ethyl acetate = 16), dried to give a light yellow oily liquid, yield 36%, 1 HNMR (500mhz, chloroform-d) δ 8.22 (d, J =8.7hz, 1h), 7.78 (d, J =6.8hz, 2h), 7.58 (s, 2H), 7.48 (d, J =3.7hz, 1h), 7.42-7.31 (m, 5H), 4.15 (d, J =17.2hz, 1h), 3.77 (d, J =17.2hz, 1h), 2.73 (s, 3H). The specific hydrogen spectrum is shown in FIG. 3.
Example 4: preparation of 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenyl-3-chlorobenzoate (I-22):
Figure BDA0003936242660000122
in a 25ml single-mouth bottle1.88g (5 mmol) of 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenol and 15mL of ethyl acetate were added, 0.94g (6 mmol) of 3-chlorobenzoic acid, 0.66g (6.5 mmol) of triethylamine, 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide, 1.90g (10 mmol) and 6mg (0.25 mmol) of 4-dimethylaminopyridine were added, the reaction was stirred at room temperature for 24h, column chromatography purification (petroleum ether: ethyl acetate = 16) was performed, and drying was carried out to obtain 0.975g of a pale yellow solid, yield 38%, melting point: the temperature of the mixture is between 128.5 and 130.2 ℃, 1 HNMR(500MHz,Chloroform-d)δ8.22(s,1H),8.13(d,J=6.5Hz,1H),7.79(d,J=6.6Hz,2H),7.67(d,J=8.6Hz,1H),7.57(s,2H),7.52(t,J=7.9Hz,1H),7.47(s,1H),7.35(d,J=8.7Hz,2H),4.15(d,J=17.1Hz,1H),3.77(d,J=17.2Hz,1H).
example 5: preparation of 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenyl-4-bromobenzoate (I-26).
Figure BDA0003936242660000131
In a 25mL single-neck flask were charged 1.88g (5 mmol) of 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenol, 0.66g (6.5 mmol) of triethylamine and 15mL of dichloromethane, and then under ice-bath conditions (0 ℃), to this was added dropwise a solution of 1.31g (6 mmol) of 4-bromobenzoyl chloride in 5mL of dichloromethane, which was reacted at room temperature for 30min, stirred at room temperature for 24h, purified by column chromatography (petroleum ether: ethyl acetate = 15): the temperature of the mixture is between 137.4 and 139.7 ℃, 1 HNMR(500MHz,Chloroform-d)δ8.10(d,J=8.5Hz,2H),7.78(d,J=8.8Hz,2H),7.71(d,J=8.5Hz,2H),7.57(s,2H),7.47(s,1H),7.33(d,J=24.3Hz,2H),4.14(d,J=17.2Hz,1H),3.76(d,J=17.2Hz,1H).
example 6: preparation of 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenyl-2-nitrobenzoate (I-27).
Figure BDA0003936242660000132
At 25m1-one-neck flask was charged with 1.9g (5 mmol) of 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenol and 15mL of toluene, added with 1.0g (6 mmol) of 3-nitrobenzoic acid, 0.66g (6.5 mmol) of triethylamine, 1.2g (6 mmol) of dicyclohexylcarbodiimide and 6mg (0.25 mmol) of 4-dimethylaminopyridine and stirred at room temperature for 24h, purified by column chromatography (petroleum ether: ethyl acetate = 16) and dried to give 0.70g of a light yellow solid, yield 28%, melting point: the temperature of the mixture is between 146.8 and 148.5 ℃, 1 HNMR(500MHz,Chloroform-d)δ8.11(d,J=9.2Hz,1H),7.93(d,J=9.2Hz,1H),7.81(dd,J=18.8,8.8Hz,4H),7.57(s,3H),7.47(s,1H),7.39(d,J=8.7Hz,2H),4.14(d,J=17.1Hz,1H),3.76(d,J=17.2Hz,1H).
according to the same method as the method for preparing the compounds such as the compound I-18 and the like, the corresponding products I-19 to I-21, I-23 to I-25 and I-28 to I-30 can be obtained by only replacing various substituted benzoic acids with 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenol 1 The HNMR spectra data are shown below.
The compound 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenyl-3-methylbenzoate (I-19): pale yellow solid, yield 38%, melting point: 99.5 to 101.3 ℃, 1 HNMR(500MHz,Chloroform-d)δ8.21(d,J=8.9Hz,1H),7.78(d,J=8.6Hz,2H),7.57(d,J=15.6Hz,3H),7.42–7.31(m,4H),4.15(d,J=17.2Hz,1H),3.77(d,J=17.1Hz,1H),2.73(s,3H).
the compound 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenyl-4-methylbenzoate (I-20): pale yellow solid, yield 40%, melting point: the temperature of the mixture is between 116.2 and 118.3 ℃, 1 HNMR(500MHz,Chloroform-d)δ8.05(d,J=5.7Hz,2H),7.78(d,J=8.7Hz,2H),7.58(s,2H),7.51(d,J=7.9Hz,1H),7.49–7.44(m,2H),7.36(d,J=8.7Hz,2H),4.15(d,J=17.1Hz,1H),3.76(d,J=17.2Hz,1H),2.49(t,J=13.9Hz,3H).
the compound 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenyl-2-chlorobenzoate (I-21): pale yellow solid, yield 42%, melting point: the temperature of the mixture is between 91.1 and 92.3 ℃, 1 HNMR(500MHz,Chloroform-d)δ8.09(d,J=7.8Hz,1H),7.78(d,J=8.7Hz,2H),7.57(d,J=3.9Hz,4H),7.51–7.42(m,2H),7.38(d,J=8.7Hz,2H),4.15(d,J=17.1Hz,1H),3.77(d,J=17.2Hz,1H).
the compound 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenyl-4-chlorobenzoate (I-23): pale yellow solid, yield 39%, melting point: 119.8-122.1 ℃ of, 1 HNMR(500MHz,Chloroform-d)δ8.18(d,J=8.6Hz,2H),7.78(s,2H),7.56(d,J=7.5Hz,4H),7.48(s,1H),7.40–7.28(m,2H),4.15(d,J=17.2Hz,1H),3.76(d,J=17.2Hz,1H).
the compound 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenyl-2-bromobenzoate (I-24): white solid, yield 37%, melting point: the temperature of the mixture is between 102.4 and 104.3 ℃, 1 HNMR(500MHz,Chloroform-d)δ8.06(dd,J=7.4,2.1Hz,1H),7.79(d,J=8.8Hz,3H),7.57(s,2H),7.53–7.44(m,3H),7.40(d,J=8.7Hz,2H),4.15(d,J=17.1Hz,1H),3.76(d,J=17.2Hz,1H).
the compound 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenyl-3-bromobenzoate (I-25): white solid, yield 32%, melting point: the temperature of the mixture is between 123.3 and 125.6 ℃, 1 HNMR(500MHz,Chloroform-d)δ8.39(d,J=14.3Hz,1H),8.17(d,J=7.8Hz,1H),7.80(dd,J=22.2,8.5Hz,3H),7.57(s,2H),7.51–7.42(m,2H),7.34(d,J=9.2Hz,2H),4.15(d,J=17.1Hz,1H),3.77(d,J=17.2Hz,1H).
the compound 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenyl-3-nitrobenzoate (I-28): pale yellow solid, yield 20%, melting point: 151.2-152.8 ℃ of the total weight of the mixture, 1 HNMR(500MHz,Chloroform-d)δ9.06(s,1H),8.56(t,J=7.7Hz,2H),7.81(d,J=8.2Hz,3H),7.57(s,2H),7.47(s,1H),7.38(d,J=8.3Hz,2H),4.16(d,J=17.3Hz,1H),3.78(d,J=17.2Hz,1H).
the compound 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenyl-4-nitrobenzoate (I-29): pale yellow solid, yield 25%, melting point: 196.7 to 198.8 ℃ of pure natural mineral, 1 HNMR(500MHz,Chloroform-d)δ8.42(s,3H),7.90–7.78(m,2H),7.57(d,J=3.5Hz,2H),7.49(s,1H),7.39(d,J=8.8Hz,1H),7.31(s,2H),4.15(d,J=17.2Hz,1H),3.77(d,J=17.2Hz,1H).
the compound 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenyl-4-trifluoromethyl benzoate (I-30): white solid, yield 34%, melting point: the temperature of the mixture is between 156.3 and 158.7 ℃, 1 HNMR(500MHz,Chloroform-d)δ8.36(d,J=8.1Hz,2H),7.82(dd,J=21.1,8.4Hz,4H),7.58(s,2H),7.47(s,1H),7.37(d,J=8.4Hz,2H),4.16(d,J=17.2Hz,1H),3.78(d,J=17.2Hz,1H).
example 7: preparation of 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenyl-propylcarbamate (I-31):
Figure BDA0003936242660000151
in a 50ml single-necked flask, 1.88g (5 mmol) of 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenol, 1.8g (NPC, 6 mmol) of bis (4-nitrophenyl) carbonate, 59.86mg (0.5 mmol) of DMAP, and 0.33g (5.5 mmol) of propylamine were charged, and the mixture was stirred at room temperature for 2 to 24 hours. Column chromatography purification (petroleum ether: ethyl acetate = 8): the temperature of the mixed solution is between 103.4 and 105.1 ℃, 1 HNMR (500mhz, chloroform-d) δ 7.69 (d, J =8.7hz, 2h), 7.56 (s, 2H), 7.47 (s, 1H), 7.25 (d, J =8.7hz, 2h), 4.11 (d, J =17.2hz, 1h), 3.73 (d, J =17.2hz, 1h), 3.29 (q, J =7.0hz, 2h), 1.65 (q, J =7.3hz, 2h), 1.02 (t, J =7.5hz, 3h). The hydrogen spectrum is shown in detail in FIG. 4.
The corresponding products I-32 to I-35 can be obtained by following the same method as the preparation of the compound I-31 and only replacing the substituted ammonia with 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenol, and the appearance, yield, melting point and content of the compound 1 The HNMR spectra data are shown below.
The compound 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenyl-diisopropylcarbamate (I-32): white solid, yield 38%, melting point: 99.9-102.3 ℃ of the total weight of the mixture, 1 HNMR(500MHz,Chloroform-d)δ8.09(s,2H),7.49(d,J=8.8Hz,1H),7.34(s,1H),7.13(d,J=9.2Hz,2H),7.04(d,J=8.8Hz,1H),3.87(dd,J=28.7,16.3Hz,4H),1.15(s,12H).
the compound 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenyl-cyclohexanecarbamate (I-33): white solid, yield 45%, melting point: 135.4-136.5 ℃ of water, 1 HNMR(500MHz,Chloroform-d)δ7.69(d,J=8.4Hz,2H),7.55(s,2H),7.47(s,1H),7.25(d,J=8.6Hz,2H),4.11(d,J=17.2Hz,1H),3.73(d,J=17.2Hz,1H),3.65–3.54(m,1H),1.79(dd,J=9.6,4.3Hz,2H),1.72–1.60(m,2H),1.48–1.36(m,2H),1.35–1.20(m,4H).
the compound 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenyl-diethyl carbamate (I-34): white solid, yield 44%, melting point: 114.3-115.6 ℃ of the total weight, 1 HNMR(500MHz,Chloroform-d)δ7.69(d,J=8.7Hz,2H),7.56(s,2H),7.46(s,1H),7.25(d,J=8.7Hz,2H),4.11(d,J=17.1Hz,1H),3.73(d,J=17.2Hz,1H),3.61–3.31(m,4H),1.28(dt,J=23.7,6.2Hz,6H).
compound 4- (5- (3, 5-dichlorophenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-yl) phenyl-buta rbamate (I-35) is a white solid in 52% yield, melting point: the temperature of the mixture is between 96.7 and 97.3 ℃, 1 HNMR(500MHz,Chloroform-d)δ7.68(d,J=8.5Hz,2H),7.55(s,2H),7.46(s,1H),7.24(d,J=8.6Hz,2H),4.11(d,J=17.1Hz,1H),3.72(d,J=17.3Hz,1H),3.32(q,J=6.9Hz,2H),1.62(q,J=7.3Hz,2H),1.44(q,J=7.4Hz,2H),1.00(t,J=7.3Hz,3H).
example 8: insecticidal activity of compound against 4 kinds of pests
The insecticidal activity test of the compound of the formula I selects various healthy and consistently-aged pests such as pea aphids, diamond back moths, sticky insects, wigglers and the like as test insects, and is provided by the research center of biological pesticide engineering technology in Shaanxi province. The indoor activity test is carried out by adopting methods such as a spraying method and the like, and the method comprises the following steps:
according to the agricultural industry standard, the synthesized compound is dissolved in a small amount of acetone, and a 200 mu g/mL medicament is prepared by using a 1 per mill tween-80 aqueous solution for later use. Preparing broad bean leaves with the same size, wrapping petioles of the broad bean leaves with absorbent cotton dipped in water for moisturizing, and putting the broad bean leaves into a culture dish with filter paper and the diameter of 9 cm. And taking another empty culture dish with the diameter of 9cm, picking at least 30 heads of the pea aphids by using a small writing brush, placing the culture dish under a Potter spray tower for 1mL of spraying liquid, settling for 5s, and taking out the culture dish. And inoculating the processed aphids into a culture dish with broad bean leaves. Repeating the treatment for 3 times, using a water solvent treatment containing 1 per thousand of Tween-80 as a control, placing the treated product in a constant-temperature illumination incubator with the temperature of 25 +/-1 ℃, the relative humidity of 80% +/-5% and the light cycle of L/D =16/8h for culture, checking treated test insects after 72h treatment, counting the death number of each treatment by touching the treated test insects with a writing brush, calculating the death rate and correcting the death rate, and using the death rate of the control treatment below 10% as an effective test.
Figure BDA0003936242660000161
Figure BDA0003936242660000162
Dissolving the synthesized compound in a small amount of acetone, and preparing into 200 μ g/mL medicament with 1 ‰ Tween-80 water solution for use. Cutting fresh corn leaves into small-leaf discs with the diameter of 1 x 1cm, placing the small-leaf discs into a test medicament, soaking for 3 seconds, taking out the small-leaf discs, naturally airing, placing the small-leaf discs into a culture dish (the diameter is 9 cm) containing filter paper for moisture preservation, inoculating 3-year-old armyworms hungry for 4 hours, repeating the treatment for 3 times, repeating 30 times for each treatment, treating the treated test insects by using a water solvent containing 1 per thousand of Tween-80 as a control, placing the treated test insects into an insect-raising room at the temperature of 25 +/-1 ℃, the relative humidity of 75 +/-5% and the light period of L/D =12/12h for feeding, counting the number of dead insects after 48 hours, wherein the death standard is that the test insects cannot be eaten, and the test brushes cannot move by touching lightly. Mortality was calculated according to the following formula, corrected for mortality, and control treatment mortality below 10% was a valid test.
Figure BDA0003936242660000171
Figure BDA0003936242660000172
The synthesized compound is dissolved in a small amount of acetone, and a 200 mu g/mL medicament is prepared by using 1 per mill of Tween-80 aqueous solution for standby. Cutting fresh cabbage leaves into small-leaf discs with the diameter of 1 x 1cm, placing the small-leaf discs into a test reagent for dipping for 3 seconds, taking out the small-leaf discs, naturally airing the small-leaf discs, placing the small-leaf discs into a culture dish (the diameter is 9 cm) containing filter paper for moisture preservation, inoculating 3-year-old diamondback moths starved for 4 hours, repeating the treatment for 3 times, repeating 30 times for each treatment, treating the treated test insects by using a water solvent containing 1 per thousand of tween-80 as a control, placing the treated test insects into an insect-raising room at the temperature of 25 +/-1 ℃, the relative humidity of 75 +/-5% and the light cycle of L/D =12/12h for feeding, counting the number of dead insects after 48 hours, wherein the death standard is that the test insects cannot be taken and the test insects cannot move by touching with a writing brush. Mortality was calculated according to the following formula, corrected for mortality, and control treatment mortality below 10% was a valid test.
Figure BDA0003936242660000173
Figure BDA0003936242660000174
Dissolving the synthesized compound in a small amount of acetone, preparing a medicament of 50 mu g/mL with a water solution of 1 thousandth Tween-80 for standby, adding 2mL of liquid medicine into each hole of a 24-hole plate, inoculating about 15 wigglers of 3 years old, repeating the treatment for 3 times, placing the treated test insects in an insect room at the temperature of 25 +/-1 ℃, the relative humidity of 75 +/-5% and the photoperiod of L/D =12/12h for feeding, using water containing 1 thousandth Tween-80 as a control, checking the number of dead and live insects under a binocular dissecting mirror after 48h, and calculating the mortality and correcting the mortality, wherein the effective test is that the mortality of the control treatment is below 10%.
Figure BDA0003936242660000181
Figure BDA0003936242660000182
The in vitro insecticidal activity data of some compounds are shown in table 2.
Table 2: activity measurement results of isoxazoline ester derivatives: corrected mortality/%
Figure BDA0003936242660000183
Figure BDA0003936242660000191
As can be seen from table 2, the compounds of formula I provided by the present invention have a certain pesticidal activity against all 4 pests tested. Wherein, the insecticidal activity of the compounds I-01 to I-07 on oriental armyworm and wiggler is more than 80 percent, and simultaneously, the insecticidal activity on diamond back moth is also excellent.
The data in table 2 show that the compound of formula I has certain insecticidal activity on oriental armyworm, pea aphid, diamond back moth and wiggler, wherein the insecticidal activity on the oriental armyworm, the diamond back moth and the wiggler is most obvious, and the compound can be used as an insecticide for controlling the insect pests.
The preferred embodiments of the present disclosure have been described in detail above, however, the present disclosure is not limited to the specific details of the above embodiments, and various simple modifications may be made to the technical solution of the present disclosure within the technical idea of the present disclosure, and these simple modifications all fall within the protection scope of the present disclosure.
It should be noted that, in the foregoing embodiments, various features described in the above embodiments may be combined in any suitable manner, and in order to avoid unnecessary repetition, various combinations that are possible in the present disclosure are not described again.
In addition, any combination of various embodiments of the present disclosure may be made, and the same should be considered as the disclosure of the present disclosure as long as it does not depart from the gist of the present disclosure.

Claims (10)

1. An ester compound containing isoxazoline is characterized by being a compound shown as a formula I;
Figure FDA0003936242650000011
in the formula: a. The 1 One of substituted or unsubstituted benzene ring, nitrogen-containing heterocycle and oxygen-containing heterocycle is selected, the substitution mode is monosubstituted or polysubstituted, and the substituent is: one of hydrogen, C1-C12 alkyl, halogenated C1-C12 alkyl, C1-C12 alkoxy, halogenated C1-C12 alkoxy, C3-C12 cycloalkyl, C1-C12 alkylthio, C2-C12 alkenyl, C2-C12 alkenylthio, halogenated C2-C12 alkenyl, C2-C12 alkynyl, halogenated C2-C12 alkynyl, halogen, cyano, nitro and benzyloxy.
R 1 One selected from the group consisting of hydrogen, C1-C12 alkyl, haloC 1-C12 alkyl, C1-C12 alkoxy, haloC 1-C12 alkoxy, C3-C12 cycloalkyl, C1-C12 alkylthio, C2-C12 alkenyl, C2-C12 alkenylthio, haloC 2-C12 alkenyl, C2-C12 alkynyl, haloC 2-C12 alkynyl, halogen, cyano, nitro and benzyloxy;
A 2 the substituted heterocyclic ring is one of substituted or unsubstituted benzene ring, nitrogen-containing heterocyclic ring, oxygen-containing heterocyclic ring and sulfur-containing heterocyclic ring, the substitution mode is single substitution or multiple substitution, and the substituent is selected from one of hydrogen, C1-C12 alkyl, halogenated C1-C12 alkyl, C1-C12 alkoxy, halogenated C1-C12 alkoxy, C3-C12 cycloalkyl, C1-C12 alkylthio, C2-C12 alkenyl, C2-C12 alkenylthio, halogenated C2-C12 alkenyl, C2-C12 alkynyl, halogenated C2-C12 alkynyl, halogen, cyano, nitro and benzyloxy;
x is C or S;
n is 1 or 2;
R 2 selected from the group consisting of C1-C12 alkyl, haloC 1-C12 alkyl, C1-C12 alkoxy, haloC 1-C12 alkoxy, C3-C12 cycloalkyl, haloC 3-C12 cycloalkyl, C1-C12 alkylthio, C2-C12 alkenyl, C2-C12 alkenylthio, haloC 2-C12 alkenyl, C2-C12 alkynyl, haloC 2-C12 alkynyl, C1-C12 alkylamino, haloC 1-C12 alkylamino, C1-C12 alkylaminocarbonyl, C1-C12 alkylsulfonyl, C1-C12 alkylsulfinyl, haloC 1-C12 alkylsulfinylOne of sulfonyl, C1-C12 alkylaminosulfonyl, di (C1-C12 alkyl) aminosulfonyl, acetyl and formyl;
or, R 2 One of unsubstituted or substituted benzene ring, nitrogen-containing heterocycle, oxygen-containing heterocycle and sulfur-containing heterocycle is selected, the substitution mode is mono-substituted or polysubstituted, and the substituent is as follows: one of hydrogen, C1-C12 alkyl, halogenated C1-C12 alkyl, C1-C12 alkoxy, halogenated C1-C12 alkoxy, C3-C12 cycloalkyl, C1-C12 alkylthio, C2-C12 alkenyl, C2-C12 alkenylthio, halogenated C2-C12 alkenyl, C2-C12 alkynyl, halogenated C2-C12 alkynyl, acetyl, formyl, halogen, cyano, nitro and benzyloxy.
2. An ester compound containing isoxazoline is characterized by being a compound shown as a formula I;
Figure FDA0003936242650000021
specific substituents in formula i are shown in the following table:
Figure FDA0003936242650000022
Figure FDA0003936242650000031
3. a method for producing an isoxazoline-containing ester compound, characterized in that the isoxazoline-containing ester compound is the isoxazoline-containing ester compound according to claim 1 or 2;
the method comprises the following steps: reacting a compound shown in a formula II with a compound shown in a formula III or a compound shown in a formula IV in an organic solvent to obtain a compound shown in a formula I:
Figure FDA0003936242650000032
4. the method of preparing isoxazoline-containing ester compounds according to claim 3, wherein the organic solvent is mixed with an additive selected from one or more of triethylamine, pyridine, dicyclohexylcarbodiimide, 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide, 4-dimethylaminopyridine and bis (4-nitrophenyl) carbonate, and the organic solvent is selected from one of dichloromethane, toluene, ethyl acetate and tetrahydrofuran.
5. The method for preparing an isoxazoline-containing ester compound according to claim 3 or 4, wherein the reaction temperature is 0 to 55 ℃ and the reaction time is 5min to 24 hours.
6. The method for preparing an isoxazoline-containing ester compound according to claim 3 or 4, wherein the molar ratio of the compound represented by the formula III to the compound represented by the formula II is 1 (0.5 to 1.5); the molar ratio of the compound shown in the formula IV to the compound shown in the formula II is 1 (0.5-1.5).
7. Use of the isoxazoline-containing ester compound according to any one of claims 1 to 2 or the isoxazoline-containing ester compound produced by the method for producing the isoxazoline-containing ester compound according to any one of claims 3 to 6 for producing an insecticide.
8. The use as claimed in claim 7, wherein said insecticide is for the control of wigglers, mythimna, piper pisum or Plutella xylostella.
9. An insecticide containing the isoxazoline-containing ester compound according to any one of claims 1 to 2 or the isoxazoline-containing ester compound produced by the method for producing the isoxazoline-containing ester compound according to any one of claims 3 to 6.
10. The insecticide as claimed in claim 9, wherein said insecticide is used for the control of diamondback moth, armyworm, pea aphid or wiggler.
CN202211404419.4A 2022-11-10 2022-11-10 Ester compound containing isoxazoline, preparation method and application Active CN115650929B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202211404419.4A CN115650929B (en) 2022-11-10 2022-11-10 Ester compound containing isoxazoline, preparation method and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202211404419.4A CN115650929B (en) 2022-11-10 2022-11-10 Ester compound containing isoxazoline, preparation method and application

Publications (2)

Publication Number Publication Date
CN115650929A true CN115650929A (en) 2023-01-31
CN115650929B CN115650929B (en) 2024-03-15

Family

ID=85021240

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202211404419.4A Active CN115650929B (en) 2022-11-10 2022-11-10 Ester compound containing isoxazoline, preparation method and application

Country Status (1)

Country Link
CN (1) CN115650929B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101652354A (en) * 2007-04-10 2010-02-17 拜尔农作物科学股份公司 insecticidal aryl isoxazoline derivatives
CN114394963A (en) * 2022-01-12 2022-04-26 西北农林科技大学 Isoxazoline compound, preparation method and application

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101652354A (en) * 2007-04-10 2010-02-17 拜尔农作物科学股份公司 insecticidal aryl isoxazoline derivatives
CN114394963A (en) * 2022-01-12 2022-04-26 西北农林科技大学 Isoxazoline compound, preparation method and application

Also Published As

Publication number Publication date
CN115650929B (en) 2024-03-15

Similar Documents

Publication Publication Date Title
KR101565853B1 (en) Spirocyclic isoxazoline derivatives as antiparasitic agents
KR930009443B1 (en) Phenoxyalkylamine derivative production
KR0161533B1 (en) Milbemycin ether derivatives, their preparation and their anthelmin
JP5299604B2 (en) Haloalkylsulfonanilide derivatives or salts thereof, herbicides containing the same as active ingredients, and methods of use thereof
JP2005314407A (en) New haloalkylsulfonanilide derivative, herbicide, method for using the same and intermediate therefor
EA029853B1 (en) 3,5-disubstituted-4,5-dihydro-1,2,4-oxadiazoles for controlling nematode pests
EP3075729B1 (en) Pyrazole amide compound and application thereof
CA2805354C (en) Herbicidal isoxazolo[5,4-b]pyridines
CN102746282A (en) N-5-substituted phenyl-2-furoyl compounds, preparation method and application thereof
CN115650929B (en) Ester compound containing isoxazoline, preparation method and application
KR20040111382A (en) Cyclic compound, process for producing the same, and pest control agent
CN114394963A (en) Isoxazoline compound, preparation method and application
US9133172B2 (en) Dihydrofuran azetidine derivatives as antiparasitic agents
JP2849389B2 (en) New macrolide compound
EP0271975A1 (en) 3-Perfluoroalkyl-isoxazol-5-yl-oxycarboxylic acid derivatives, processes for their preparation and their use as herbicides
JPH0251549B2 (en)
EP0032748A1 (en) Thiophene derivatives
JP4645871B2 (en) Isoxazoline derivatives, herbicides and methods of use thereof
CN111303126A (en) Pyrazole amide compound and application thereof as herbicide
JPH05271199A (en) N-substituted-3-@(3754/24)substituted hydrazino) benzenesulfonamide derivative, its production and herbicide
CN117567446B (en) Triazolinone compound containing heterocyclic structure, preparation method and application thereof
JPS61126065A (en) Substituted phenoxyurea, its preparation, herbicide containing same as an active intredient
JPH0421671A (en) 4-pyrazolecarboxamides and insecticide and acaricide containing the same as active ingredient
CN116731003A (en) N-phenylimine-containing derivative, and preparation method and application thereof
JP3783353B2 (en) Phosphorus compounds, their production methods and pesticides for agriculture and horticulture

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant